Physician profile
Michael K Block
NPI 1750467338
$1,871.39
in general payments reported to CMS, 2019-2025
28 companies · $41.68 in 2025
The $41.68 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $223 · 2021: $523 · 2022: $293 · 2023: $104 · 2024: $95.45 · 2025: $41.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $421.96 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $276.11 | 2019-2023 | Arazlo, Jublia |
| Organogenesis INC. | $127.21 | 2021-2024 | Novachor |
| Smith+Nephew, INC. | $108.99 | 2019-2023 | Collagenase Santyl |
| Pfizer INC. | $97.71 | 2019-2020 | |
| Grt US Holding, INC. | $75.53 | 2021-2022 | |
| Bioventus LLC | $65.46 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Melinta Therapeutics, LLC | $64.21 | 2019 | |
| Paratek Pharmaceuticals, INC. | $63.67 | 2021-2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $56.44 | 2021-2023 | |
| Ibsa Pharma INC. | $54.90 | 2020-2024 | Licart, Tirosint |
| Sebela Pharmaceuticals INC. | $46.95 | 2020-2022 | |
| Abbvie INC. | $46.70 | 2021 | |
| Paragon 28, INC. | $43.94 | 2019-2020 | |
| Solventum Corporation | $43.68 | 2024-2025 | Activ.A.C., Promogran Prisma |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $41.39 | 2019 | |
| Mayne Pharma Commercial LLC | $41.21 | 2021-2022 | |
| Alfasigma USA, INC. | $27.88 | 2020-2021 | |
| Supreme Orthopedic Systems, LLC | $25.79 | 2019 | |
| Abbott Laboratories | $20.98 | 2022 | |
| Journey Medical Corporation | $20.36 | 2021 | |
| Tactile Systems Technology INC | $18.04 | 2019 | |
| Medtronic, INC. | $17.92 | 2025 | Closurefast |
| Medtronic Vascular, INC. | $17.22 | 2020 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Wright Medical Technology, INC. | $13.57 | 2019 | |
| Integra Lifesciences Corporation | $11.05 | 2019 | |
| Medela LLC | $8.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.